About us>Leadership team

Leadership team

From The Mind Come Drugs of the Future

Art E. Cho, Ph. D.

(Founder & CEO)

Education

  • California Institute of Technology, Pasadena, CA, Postdoctoral Scholar, Materials and Process Simulation Center
  • Brown University, Providence, RI, Ph. D., Department of Physics
  • Brown University, Providence, RI, M.S., Department of Physics
  • University of Chicago, Chicago, IL, Department of Astronomy and Astrophysics, Department of Mathematics
  • University of California at Berkeley, Berkeley, CA, B.S., Double major in Mathematics and Physics

Experience

  • Founder and CEO, inCerebro Co.
  • Founder, President and CSO, Quantum Bio Solutions
  • Professor, Department of Bioinformatics and Biotechnology, Korea University
  • Applications Scientist, Schrödinger Inc.
  • Research Scientist, Center for Biomolecular Simulations, Columbia University
  • Senior Research Scientist, Parallel Supercomputing Application Laboratory, Samsung Advanced Institute of Technology

Eunho Lee, Ph. D.

(CTO)

Education

  • Dankook University, Ph. D., Pharmacology
  • Sogang University, M.S., Development of biology
  • Sogang University, B.S., Department of Life Sciences

Experience

  • Chief Technical Officer (inCerebro), inCerebro Co.
  • R&D Managing Director, Genemedicine Inc.
  • CTO and CEO, Generys Korea
  • Principle Researcher, Oscotec Inc.
  • Senior Researcher, SK Inc. Drug Discovery Department
  • Researcher, SK Biopharmaceuticals Co. Biotechnology Lab.

Sangbae Lee, Ph. D.

(CSO)

Education

  • Indiana University Bloomington, Postgraduate Degree
  • University of Florida, Ph. D., Computational Chemistry

Experience

  • Chief Scientific Officer (inCerebro), inCerebro Co.
  • Cheir Researcher, In-Silico (Computer Aided Drug Design), Syntekabio, Inc.
  • In-Silico Director, Pharmcadd
  • Staff Scientist, (Ant)agonist Design for GPCR & Kinase, City of Hope, National Cancer Center
  • Postdoctoral Research Fellow, GPCR MD Simulation, the city of hope
  • Postdoctoral Fellow, New Antibiotics Design using Molecular Mechanics, Indiana University Bloomington

Jon Junyoung Huh, Ph. D.

(CFO)

Education

  • Korea University, Finance & Accounting
  • Ph. D. of Finance & Accounting
  • KICPA
  • AICPA
  • CFA (L1)

Experience

  • Adjunct professor of Chung-Ang University
  • Audit committee chairman of Cuckoo Holdings
  • Audit committee chairman of GMB Korea
  • EY Korea Assurance leader (2018)
  • International Finance and Investments (2021, PY Book)

Evan (Sanghwan) Kang, M.S.

(CBO)

Education

  • Ajou University School of Medicine, M.S., Neuroscience
  • Sogang University, B.S., Life Science, Chemistry (Dual)

Experience

  • External Innovation Director, WhanIn Pharm. Co., Ltd.
  • Business Development Director, Huons Co., Ltd.
  • Business Developmet Senior Manager, SK Chemicals Co., Ltd.
  • Research Scientist, LG Chem, Ltd.

Art E. Cho, Ph. D.

(Founder & CEO)

Eunho Lee, Ph. D.

(CTO)

Sangbae Lee, Ph. D.

(CSO)

Jon Junyoung Huh, Ph. D.

(CFO)

Evan (SangHwan) Kang, M.S.

(CBO)

TOP